John Hamm

Insider Reports History

Location
Nashville, TN
Signature
/s/ John Hamm
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hamm:

Company Role Class Num Shares Value Price $ Report Date Ownership
CUMBERLAND PHARMACEUTICALS INC VP Chief Financial Officer Common Stock 20,073 $109,599 $5.46 16 Mar 2025 Direct
CUMBERLAND PHARMACEUTICALS INC VP Chief Financial Officer Options (right to buy) 15,250 $78,843 $5.17 17 Mar 2025 Direct

Insider Reports Filed by John Hamm

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CPIX CUMBERLAND PHARMACEUTICALS INC 16 Mar 2025 2 -$18,160 4 VP Chief Financial Officer 18 Mar 2025, 17:06
CPIX CUMBERLAND PHARMACEUTICALS INC 23 Mar 2024 2 +$8,600 4 VP Chief Financial Officer 26 Mar 2024, 20:22
CPIX CUMBERLAND PHARMACEUTICALS INC 27 Nov 2023 1 -$588 4 Chief Financial Officer 06 Dec 2023, 17:05
CPIX CUMBERLAND PHARMACEUTICALS INC 24 Mar 2023 1 $0 4 Chief Financial Officer 27 Mar 2023, 17:53
CPIX CUMBERLAND PHARMACEUTICALS INC 16 Mar 2022 2 +$51,800 4 Chief Financial Officer 29 Apr 2022, 13:02
CPIX CUMBERLAND PHARMACEUTICALS INC 23 Nov 2021 1 +$8,930 4 Chief Financial Officer 03 Dec 2021, 16:15
CPIX CUMBERLAND PHARMACEUTICALS INC 17 May 2021 0 $0 3 Chief Financial Officer 09 Jul 2021, 17:08